BARRIER REVERSE CONVERTIBLE - MERCK/BAYER/SANOFI Stock

Certificat

RMBQPV

CH1275372816

Delayed Swiss Exchange 11:20:01 2024-05-13 am EDT
57 EUR +1.60% Intraday chart for BARRIER REVERSE CONVERTIBLE - MERCK/BAYER/SANOFI
Current year-25.97%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-13 57 +1.60%

Delayed Quote Swiss Exchange

Last update May 13, 2024 at 11:20 am EDT

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying MERCK KGAA
IssuerLogo Issuer Vontobel Vontobel
RMBQPV
ISINCH1275372816
Date issued 2023-07-28
Strike 160.4
Maturity 2024-07-29 (69 Days)
Parity 0.16 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 100.5
Lowest since issue 56.1

Company Profile

Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Sector
-
More about the company

Ratings for Merck KGaA

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Merck KGaA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
166.6 EUR
Average target price
182.3 EUR
Spread / Average Target
+9.46%
Consensus
  1. Stock Market
  2. Certificates
  3. RMBQPV Certificat
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW